Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (scFv-CH3) contains two chains. The anti-CD30 scFv is fused to the Knob-CH3 domain via a hinge region and the same as the anti-CD64 scFv to the Hole-CH3 domain, or vice versa. The KIH CH3 domains can facilitate to form a heterodimer and this bivalent binding leads to improvement in avidity. This BsAb can retarget neutrophilscells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (scFv-CH3) (BSFC-110). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS